BIRC5 and breast carcinoma: Treatment of metastatic breast cancer cells with paclitaxel or nocodazole, but not drugs with other mechanisms of action, causes the cells to release exosomes with high levels of Survivin. These Survivin-containing exosomes promote survival of serum-starved fibroblasts and cancer cells.